| 英文別名： |
17A-hydroxyprogesterone;17-Alpha-Hydroxy-Progesterone;17-alpha-hydroxypregn-4-ene-3,20-dione;2-Chloro-5-Fluorobenzoic Acid;17alpha-Hydroxyprogesterone;17-Hydroxyprogesterone;17α-Hydroxy Progesterone;17α-Hydroxyprogesterone solution;Hydroxyprogesterone;HYDROXYPROGESTERONE, 17a-(RG);17-OHP;17α-Hydroxy-4-pregnene-3,20-dione;4-Pregnen-17a-ol-3,20-dione;17a-Hydroxypregn-4-ene-3,20-dione;Prodix;Prodox;Gestageno gador;Setaderm;Oxiprogesteronum;17-alpha-Hydroxyprogesterone;Hidroxiprogesterona;Hydroxyprogesteronum;Gestageno;Idrossiprogesterone [DCIT];17alpha-Hydroxy-progesterone;Hydroxyprogesteronum [INN-Latin];Hidroxiprogesterona [INN-;17α-Hydroxyprogesterone;17.alpha.-Hydoxyprogesterone;MLS000028453;4-08-00-02189 (Beilstein Handbook Reference);Hydroxyprogesterone (INN);hydroxyprogesteron-;17alpha-Hydroxyprogesterone, >=95%;HYDROXYPROGESTERONE [INN];s4507;17.alpha.-Hydroxyprogesterone;7A45BEF6-ADD0-4B3E-A014-2DE930D3B67B;17a-Hydroxyprogesterone;4-Pregnen-17.alpha.-ol-3,20-dione;HMS2234J04;Progesterone, 17alpha-hydroxy-;Tox21_111233_1;GTPL5104;HSDB 3343;NCGC00261250-01;FD12004;NCGC00093949-08;HYDROXYPROGESTERONE [VANDF];17-Alpha-Hydroxyprogesterone, 1mg/ml in Methanol;SMR000058349;Tox21_301530;EINECS 200-699-4;BIDD:PXR0103;D06WBH;HYDROXYPROGESTERONE [HSDB];17.alpha.-Pregn-4-ene-3,20-dione, 17-hydroxy-;LP00565;A-Hydroxyprogesterone;MLS002695950;AKOS015955623;D08052;hydroxyprogesterone;MLS001076300;AB00490003-08;17-Hydroxypregn-4-ene-3,20-dione;DB14570;17alpha-Hydroxyprogesterone, VETRANAL(TM), analytical standard;Hydroxyprogesterone [INN:BAN];17.alpha.-Hydroxypregna-4-ene-3,20-dione;DTXSID6040747;HYDROXYPROGESTERONE [WHO-DD];Epitope ID:152220;Pregn-4-ene-3,20-dione-17-ol;U-3096;17.ALPHA.-HYDROXYPREGN-4-ENE-3,20-DIONE;Hidroxiprogesterona [INN-Spanish];CCG-204655;CS-O-10309;C01176;Pregn-4-ene-3,20-dione, 17-hydroxy-;Pregn-4-en-17a-ol-3,20-dione;17-Hydroxypregn-4-ene-3,20-dione, (+/-)-;17-Hydroxypregn-4-ene-3,20-dione-, (17.alpha.)-;NCGC00255425-01;17alpha-Hydroxy-4-pregnene-3,20-dione;SCHEMBL8068;CAS-68-96-2;BRN 2062088;NSC 15468;alpha-17Hydroxypregn-4-ene-3,20-dione;NSC15468;(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one;Pregn-4-ene-3,20-dione, 17-hydroxy-, (17a)-;NCGC00093949-03;Opera_ID_1812;HMS2090M08;delta(4)-Pregnene-17alpha-ol-3,20-dione;CS-4354;17-hydroxy-progesterone;17-a-Hydroxyprogesterone;W-104646;4-Pregnen-17alpha-ol-3,20-dione;MFCD00003659;U 3096;KS-5312;68-96-2;17.ALPHA.-HYDROXYPROGESTERONE [MI];(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one;SDCCGSBI-0050548.P002;Pregn-4-ene-3,20-dione, 17-hydroxy-, (17.alpha.)-;17-Hydroxyprogeoterone;DTXCID4020747;HY-B0891;(8R,10R,13S,17R)-17-Acetyl-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetrade... |
滬公網(wǎng)安備31011402010658號(hào) 
